Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Silverman, Stuart
Language :
English
Title :
The Value of a Patient-Level Modeling Approach and Need for Better Reporting in Economic Evaluations of Osteoporosis
Publication date :
March 2020
Journal title :
Journal of Managed Care and Specialty Pharmacy
ISSN :
2376-0540
eISSN :
2376-1032
Publisher :
Academy of Managed Care Pharmacy (AMCP), United States
Le QA. Patient-level modeling approach using discrete-event simulation: a cost-effectiveness study of current treatment guidelines for women with postmenopausal osteoporosis. J Manag Care Spec Pharm. 2019;25(10): 1089-95. Available at: https://www.jmcp.org/doi/full/10.18553/jmcp.2019.25.10.1089.
Hiligsmann M, Reginster JY, Tosteson ANA et al. Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the U.S. branch of the International Osteoporosis Foundation. Osteoporos Int. 2019;30(1):45-57.
Hiligsmann M, Ethgen O, Bruyere O, Richy F, Gathon HJ, Reginster JY. Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis. Value Health. 2009; 12(5):687-96.
Hiligsmann M, Williams SA, Fitzpatrick LA, Silverman SS, Weiss R, Reginster JY. Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fracture. Semin Arthritis Rheum. 2019;49(2):184-96.
Cosman F, Nieves JW, Dempster DW. Treatment sequence matters: anabolic and antiresorptive therapy for osteoporosis. J Bone Miner Res. 2017;32(2):198-202.
McClung MR, Wagman RB, Miller PD, Wang A, Lewiecki EM. Observations following discontinuation of long-term denosumab therapy. Osteoporos Int. 2017;28(5):1723-32.
Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Aging Clin Exp Res. 2019; 31(1):15-17.